These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25415763)

  • 1. A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder.
    Ghanizadeh A
    Nord J Psychiatry; 2015 May; 69(4):241-8. PubMed ID: 25415763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.
    Tehrani-Doost M; Moallemi S; Shahrivar Z
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):179-84. PubMed ID: 18439114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial.
    Golubchik P; Sever J; Weizman A
    Clin Neuropharmacol; 2013; 36(2):37-41. PubMed ID: 23503544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.
    Ratner S; Laor N; Bronstein Y; Weizman A; Toren P
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):428-33. PubMed ID: 15843764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.
    Arabgol F; Panaghi L; Hebrani P
    Eur Child Adolesc Psychiatry; 2009 Jan; 18(1):53-9. PubMed ID: 18563471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reboxetine maintenance treatment in children with attention-deficit/hyperactivity disorder: a long-term follow-up study.
    Toren P; Ratner S; Weizman A; Lask M; Ben-Amitay G; Laor N
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):803-12. PubMed ID: 18315452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of clinical trials of aripiprazole for treating attention deficit hyperactivity disorder.
    Ghanizadeh A
    Neurosciences (Riyadh); 2013 Oct; 18(4):323-9. PubMed ID: 24141455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.
    Otka JE; Mercadante MT; Scahill L; Leckman JF
    J Child Adolesc Psychopharmacol; 2001; 11(2):203-4. PubMed ID: 11436962
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
    Riahi F; Tehrani-Doost M; Shahrivar Z; Alaghband-Rad J
    Hum Psychopharmacol; 2010 Nov; 25(7-8):570-6. PubMed ID: 21312292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine for treating ADHD symptoms in autism: a systematic review.
    Ghanizadeh A
    J Atten Disord; 2013 Nov; 17(8):635-40. PubMed ID: 22544388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
    Toren P; Ratner S; Laor N; Lerer-Amisar D; Weizman A
    Neuropsychobiology; 2005; 51(4):239-42. PubMed ID: 15897675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials.
    Ghanizadeh A; Berk M
    Eur J Clin Nutr; 2013 Jan; 67(1):122-4. PubMed ID: 23169472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].
    Mészáros A; Czobor P; Bálint S; Simon V; Bitter I
    Psychiatr Hung; 2007; 22(4):259-70. PubMed ID: 18167421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of magnesium therapy for treating attention deficit hyperactivity disorder.
    Ghanizadeh A
    Arch Iran Med; 2013 Jul; 16(7):412-7. PubMed ID: 23808779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorder.
    Jin L; Xu W; Krefetz D; Gruener D; Kielbasa W; Tauscher-Wisniewski S; Allen AJ
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):200-7. PubMed ID: 23607409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Ng QX
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):112-116. PubMed ID: 27813651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression.
    Cunill R; Castells X; Tobias A; Capellà D
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):961-9. PubMed ID: 23813665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.